​

Hinge Health Stock (NYSE:HNGE)

ForecastRevenueOwnershipFinancialsChartTranscripts
Hinge Health by TradingView

Previous Close

$45.44

52W Range

$30.08 - $62.18

50D Avg

$41.83

200D Avg

$46.98

Market Cap

$3.50B

Avg Vol (3M)

$1.26M

Beta

1.75

Div Yield

-

HNGE Company Profile

Hinge Health, Inc. develops health care software for joint and muscle health. The company designs its platform to address a musculoskeletal care, acute injury, chronic pain, and post-surgical rehabilitation. It also provides various administrative and operations support services. The company was founded in 2012 and is headquartered in San Francisco, California.

Show More

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

1,514

IPO Date

May 22, 2025

Website

HNGE Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/ServiceDec 25
Reportable Segment$587.86M

Fiscal year ends in Dec 25 | Currency in USD

HNGE Financial Summary

Dec 25Dec 24Dec 23
Revenue$587.86M$390.40M$292.73M
Operating Income$-546.37M$-24.43M$-130.51M
Net Income$-528.26M$-11.93M$-108.14M
EBITDA$-541.24M$-5.31M$-102.92M
Basic EPS$-5.36$-0.15$-1.39
Diluted EPS$-5.19$-0.15$-1.39

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts

Q4 25Feb 10, 26 | 4:30 PM
Q3 25Nov 04, 25 | 4:30 PM

Peer Comparison

TickerCompany
VKTXViking Therapeutics, Inc.
CRNXCrinetics Pharmaceuticals, Inc.
OSCROscar Health, Inc.
PRAXPraxis Precision Medicines, Inc.
INDVIndivior Pharmaceuticals Inc
DYNDyne Therapeutics, Inc.
WGSGeneDx Holdings Corp.
AKROAkero Therapeutics, Inc.
IMVTImmunovant, Inc.
LNTHLantheus Holdings, Inc.